NCT01819155View on ClinicalTrials.gov

Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa

PHASE2CompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

Adjuvanted seasonal trivalent inactivated influenza vaccine

BIOLOGICAL

Seasonal trivalent inactivated influenza vaccine

BIOLOGICAL

Saline (bacteriostatic 0.9% sodium chloride for injection)

Trial Locations (1)

Unknown

Institut de Recherche pour le Développement, Niakhar

All Listed Sponsors
collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

collaborator

Centers for Disease Control and Prevention

FED

lead

PATH

OTHER

NCT01819155 - Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa | Biotech Hunter | Biotech Hunter